Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Cancer of the Bladder, Recurrent clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Cancer of the Bladder, Recurrent: 1 US clinical trial tracked, none currently recruiting.

Cancer of the Bladder, Recurrent is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is University of Washington, running 1 of these trials.

Enrollment posture brief

Registry condition cancer-of-the-bladder-recurrent

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Cancer of the Bladder, R (th…0%
Open-enrollment share among volume-matched conditions near Cancer of the Bladder, Recurrent

Cancer of the Bladder, Recurrent has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cancer of the Bladder, Recurrent on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cancer of the Bladder, Recurrent is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

US sites by state

Facility locations filed on Cancer of the Bladder, Recurrent trials. A trial with sites in several states counts in each.

New York 1 trials
Michigan 1 trials
Maryland 1 trials
Massachusetts 1 trials
Louisiana 1 trials
Kansas 1 trials
Illinois 1 trials
Iowa 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cancer of the Bladder, Recurrent page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Cancer of the Bladder, Recurrent trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • University of Washington sponsors the most Cancer of the Bladder, Recurrent trials on record, review their full trial history before evaluating a specific study. See University of Washington's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cancer of the Bladder, Recurrent condition card totals 1 registered trials; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.